Sotrovimab Or Xevudy Market Report 2026
Download Free Sample Buy Now
Sotrovimab Or Xevudy Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Sotrovimab Or Xevudy Market Report 2026

Global Outlook – By Indication (COVID-19 Early Treatment, Post-Exposure Prophylaxis ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies ), By End User (Pediatric, Adult, Geriatric) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Sotrovimab Or Xevudy Market Overview

• The Sotrovimab Or Xevudy market growth in the historic period has been driven by emergency authorization of covid-19 monoclonal antibodies, high hospitalization risk during early pandemic phases

• Market expansion is supported by evolution of variant-resistant antibody therapies, growing focus on preparedness for future pandemics

• Growth Driver: Impact Of Rising COVID-19 Cases On Market Growth

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Sotrovimab Or Xevudy Market?

Sotrovimab (Xevudy) is a monoclonal antibody treatment developed for the management of COVID-19. It is specifically designed to target the SARS-CoV-2 spike protein, preventing the virus from entering and infecting human cells. Sotrovimab is used for treating mild-to-moderate COVID-19 in patients at high risk of progressing to severe illness, offering an effective therapeutic option in early-stage infections.

The main indication for sotrovimab or xevudy is COVID-19 early treatment and post-exposure prophylaxis. The COVID-19 early treatment refers to the use of sotrovimab (xevudy) to treat patients who are diagnosed with COVID-19 early in the course of the disease. This treatment is designed to reduce the severity of symptoms, prevent complications, and decrease the likelihood of hospitalization, particularly in individuals who are at high risk of severe disease. It is distributed through various channels such as hospitals pharmacies, retail pharmacies, and online pharmacies and is utilized by pediatric, adult, and geriatric.

Sotrovimab Or Xevudy Market Global Report 2026 Market Report bar graph

What Is The Sotrovimab Or Xevudy Market Size and Share 2026?

The growth in the historic period can be attributed to emergency authorization of covid-19 monoclonal antibodies, high hospitalization risk during early pandemic phases, rapid deployment of antibody therapies, government procurement of antiviral treatments, expansion of infusion-based treatment infrastructure.

What Is The Sotrovimab Or Xevudy Market Growth Forecast?

The growth in the forecast period can be attributed to evolution of variant-resistant antibody therapies, growing focus on preparedness for future pandemics, increased investment in antiviral biologics, expansion of outpatient infusion services, integration of monoclonal antibodies into standard care protocols. Major trends in the forecast period include increasing use of monoclonal antibody therapies, rising focus on early-stage viral treatment, expansion of targeted antiviral biologics, growing emphasis on high-risk patient protection, enhanced development of pandemic-response therapeutics.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Sotrovimab Or Xevudy Market Segmentation

1) By Indication: COVID-19 Early Treatment, Post-Exposure Prophylaxis

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By End User: Pediatric, Adult, Geriatric

What Are The Drivers Of The Sotrovimab Or Xevudy Market?

The rise in the prevalence of COVID-19 cases is expected to drive the growth of the sotrovimab or xevudy market going forward. COVID-19 is a disease caused by the SARS-CoV-2 virus, spreading through respiratory droplets and causing symptoms from mild fever to severe respiratory issues. Vaccines and hygiene practices help prevent its spread. COVID-19 cases are increasing due to factors such as new variants, reduced immunity, eased restrictions, seasonal indoor gatherings, and uneven vaccine coverage. Sotrovimab treats high-risk COVID-19 patients by neutralizing the virus early, preventing severe outcomes such as hospitalization or death. For instance, in March 2023, according to a report published by the Office for National Statistics, a UK-based government department for official statistics, as of March 2023, an estimated 1.9 million people in the UK (2.9% of the population) reported COVID. Most (92%) had COVID-19 over 12 weeks earlier, with 69% experiencing symptoms for over a year and 41% for over two years. Therefore, the rise in the prevalence of COVID cases is going to drive the growth of the sotrovimab or xevudy industry.

The rise in healthcare investments is expected to drive the growth of the sotrovimab or xevudy market going forward. Healthcare investments refers to the total amount spent on healthcare services, including medical treatments, medications, and hospital care, within a specific period. Healthcare investments is rising due to factors such as an aging population, increasing healthcare needs, advancements in medical technology, and rising prices for services and medications. Investments in healthcare boost sotrovimab (xevudy) by supporting R&D, expanding production, and improving access for high-risk patients through partnerships and distribution networks. For instance, in May 2024, according to a report published by the Office for National Statistics, a UK-based government department for official statistics, total healthcare expenditure saw a 5.6% increase in nominal terms from 2022 to 2023, marking a significant acceleration compared to the 0.9% growth observed in 2022. Therefore, the rise in healthcare investments will drive the growth of the sotrovimab or xevudy industry.

Key Players In The Global Sotrovimab Or Xevudy Market

Major companies operating in the sotrovimab or xevudy market are GSK plc, Vir Biotechnology Inc.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Sotrovimab Or Xevudy Market?

In February 2023, Vir Biotechnology, a U.S.-based biotechnology company, and GSK, a collaboration agreement to strengthen joint development efforts for Sotrovimab and VIR-7832. The updated agreement reaffirmed both companies’ commitment to advancing these monoclonal antibody programs and clarified shared responsibilities related to development, manufacturing, and commercialization. GlaxoSmithKline is a UK-based company developers and suppliers of sotrovimab

Regional Insights

North America was the largest region in the sotrovimab or xevudy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Sotrovimab Or Xevudy Market?

The sotrovimab or xevudy market consists of sales of pre-filled syringes and infusion kits. Values in this market are ‘factory gate’ values, representing the value of vaccines sold directly by manufacturers, either to governments, healthcare organizations, or distribution networks. This includes revenues from related services but excludes resales further along the supply chain or integration into other healthcare products.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Sotrovimab Or Xevudy Market Report 2026?

The sotrovimab or xevudy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sotrovimab or xevudy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Sotrovimab Or Xevudy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate No CAGR found from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Indication, Distribution Channel, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled GSK plc, Vir Biotechnology Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Sotrovimab Or Xevudy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Sotrovimab Or Xevudy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Sotrovimab Or Xevudy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Sotrovimab Or Xevudy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics And Precision Medicine

4.1.2 Artificial Intelligence And Autonomous Intelligence

4.1.3 Industry 4.0 And Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data And Cybersecurity

4.1.5 Sustainability, Climate Tech And Circular Economy

4.2. Major Trends

4.2.1 Increasing Use Of Monoclonal Antibody Therapies

4.2.2 Rising Focus On Early-Stage Viral Treatment

4.2.3 Expansion Of Targeted Antiviral Biologics

4.2.4 Growing Emphasis On High-Risk Patient Protection

4.2.5 Enhanced Development Of Pandemic-Response Therapeutics

5. Sotrovimab Or Xevudy Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Infusion Centers

5.4 Public Health Agencies

5.5 Ambulatory Care Centers

6. Sotrovimab Or Xevudy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Sotrovimab Or Xevudy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Sotrovimab Or Xevudy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Sotrovimab Or Xevudy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Sotrovimab Or Xevudy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Sotrovimab Or Xevudy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Sotrovimab Or Xevudy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Sotrovimab Or Xevudy Market Segmentation

9.1. Global Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

COVID-19 Early Treatment, Post-Exposure Prophylaxis

9.2. Global Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

9.3. Global Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pediatric, Adult, Geriatric

10. Sotrovimab Or Xevudy Market Regional And Country Analysis

10.1. Global Sotrovimab Or Xevudy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Sotrovimab Or Xevudy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Sotrovimab Or Xevudy Market

11.1. Asia-Pacific Sotrovimab Or Xevudy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Sotrovimab Or Xevudy Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Sotrovimab Or Xevudy Market

12.1. China Sotrovimab Or Xevudy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Sotrovimab Or Xevudy Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Sotrovimab Or Xevudy Market

13.1. India Sotrovimab Or Xevudy Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Sotrovimab Or Xevudy Market

14.1. Japan Sotrovimab Or Xevudy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Sotrovimab Or Xevudy Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Sotrovimab Or Xevudy Market

15.1. Australia Sotrovimab Or Xevudy Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Sotrovimab Or Xevudy Market

16.1. South Korea Sotrovimab Or Xevudy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Sotrovimab Or Xevudy Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Sotrovimab Or Xevudy Market

17.1. Western Europe Sotrovimab Or Xevudy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Sotrovimab Or Xevudy Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Sotrovimab Or Xevudy Market

18.1. UK Sotrovimab Or Xevudy Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Sotrovimab Or Xevudy Market

19.1. Germany Sotrovimab Or Xevudy Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Sotrovimab Or Xevudy Market

20.1. France Sotrovimab Or Xevudy Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Sotrovimab Or Xevudy Market

21.1. Eastern Europe Sotrovimab Or Xevudy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Sotrovimab Or Xevudy Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Sotrovimab Or Xevudy Market

22.1. North America Sotrovimab Or Xevudy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Sotrovimab Or Xevudy Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Sotrovimab Or Xevudy Market

23.1. USA Sotrovimab Or Xevudy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Sotrovimab Or Xevudy Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Sotrovimab Or Xevudy Market

24.1. Canada Sotrovimab Or Xevudy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Sotrovimab Or Xevudy Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Sotrovimab Or Xevudy Market

25.1. South America Sotrovimab Or Xevudy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Sotrovimab Or Xevudy Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Sotrovimab Or Xevudy Market

26.1. Middle East Sotrovimab Or Xevudy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Sotrovimab Or Xevudy Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Sotrovimab Or Xevudy Market

27.1. Africa Sotrovimab Or Xevudy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Sotrovimab Or Xevudy Market, Segmentation By Indication, Segmentation By Distribution Channel, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Sotrovimab Or Xevudy Market Regulatory and Investment Landscape

29. Sotrovimab Or Xevudy Market Competitive Landscape And Company Profiles

29.1. Sotrovimab Or Xevudy Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Sotrovimab Or Xevudy Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Sotrovimab Or Xevudy Market Company Profiles

29.3.1. GSK plc Overview, Products and Services, Strategy and Financial Analysis

29.3.2. Vir Biotechnology Inc. Overview, Products and Services, Strategy and Financial Analysis

30. Global Sotrovimab Or Xevudy Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Sotrovimab Or Xevudy Market

32. Sotrovimab Or Xevudy Market High Potential Countries, Segments and Strategies

32.1 Sotrovimab Or Xevudy Market In 2030 - Countries Offering Most New Opportunities

32.2 Sotrovimab Or Xevudy Market In 2030 - Segments Offering Most New Opportunities

32.3 Sotrovimab Or Xevudy Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Sotrovimab Or Xevudy Market, Overview Of Key Products - Product Examples
  • Table 2: Global Sotrovimab Or Xevudy Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Sotrovimab Or Xevudy Market, Supply Chain Analysis
  • Table 4: Global Sotrovimab Or Xevudy Market, Major Raw Material Providers
  • Table 5: Global Sotrovimab Or Xevudy Market, Major Resource Providers
  • Table 6: Global Sotrovimab Or Xevudy Market, Major Manufacturers (Suppliers)
  • Table 7: Global Sotrovimab Or Xevudy Market, Major Distributors And Channel Partners
  • Table 8: Global Sotrovimab Or Xevudy Market, Key Technologies & Future Trends
  • Table 9: Global Sotrovimab Or Xevudy Market, Major Trends
  • Table 10: Global Sotrovimab Or Xevudy Market, Major End Users
  • Table 11: Global Sotrovimab Or Xevudy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Sotrovimab Or Xevudy Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Sotrovimab Or Xevudy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Sotrovimab Or Xevudy Market - TAM, US$ Billion, 2025
  • Table 15: Global Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Sotrovimab Or Xevudy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Sotrovimab Or Xevudy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Asia-Pacific, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Asia-Pacific, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: China, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: China, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: India, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: India, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Japan, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Japan, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Australia, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Australia, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: South Korea, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: South Korea, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Western Europe, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Western Europe, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: UK, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: UK, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Germany, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Germany, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: France, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: France, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Eastern Europe, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Eastern Europe, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: North America, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: North America, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: USA, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: USA, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Canada, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Canada, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: South America, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: South America, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Middle East, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Middle East, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Africa, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Africa, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Global Sotrovimab Or Xevudy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 72: Global Sotrovimab Or Xevudy Market - Company Scoring Matrix
  • Table 73: GSK plc Financial Performance
  • Table 74: Vir Biotechnology Inc. Financial Performance
  • Table 75: Global Sotrovimab Or Xevudy Market, Competitive Benchmarking (In USD Billions)
  • Table 76: Global Sotrovimab Or Xevudy Market, Competitive Dashboard
  • Table 77: Global Sotrovimab Or Xevudy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 78: Global, Sotrovimab Or Xevudy Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 79: Global, Sotrovimab Or Xevudy Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030
  • Table 80: Global, Sotrovimab Or Xevudy Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Sotrovimab Or Xevudy Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Sotrovimab Or Xevudy Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Sotrovimab Or Xevudy Market, Supply Chain Analysis
  • Figure 4: Global Sotrovimab Or Xevudy Market, Major Raw Material Providers
  • Figure 5: Global Sotrovimab Or Xevudy Market, Major Resource Providers
  • Figure 6: Global Sotrovimab Or Xevudy Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Sotrovimab Or Xevudy Market, Major Distributors And Channel Partners
  • Figure 8: Global Sotrovimab Or Xevudy Market, Key Technologies & Future Trends
  • Figure 9: Global Sotrovimab Or Xevudy Market, Major Trends
  • Figure 10: Global Sotrovimab Or Xevudy Market, Major End Users
  • Figure 11: Global Sotrovimab Or Xevudy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Sotrovimab Or Xevudy Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Sotrovimab Or Xevudy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Sotrovimab Or Xevudy Market - TAM, US$ Billion, 2025
  • Figure 15: Global Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Sotrovimab Or Xevudy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Sotrovimab Or Xevudy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Asia-Pacific, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Asia-Pacific, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: China, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: China, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: India, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: India, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Japan, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Japan, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Australia, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Australia, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: South Korea, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: South Korea, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Western Europe, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Western Europe, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: UK, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: UK, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Germany, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Germany, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: France, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: France, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Eastern Europe, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Eastern Europe, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: North America, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: North America, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: USA, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: USA, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Canada, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Canada, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: South America, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: South America, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Middle East, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Middle East, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Africa, Sotrovimab Or Xevudy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Africa, Sotrovimab Or Xevudy Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Sotrovimab Or Xevudy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Global Sotrovimab Or Xevudy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 72: Global Sotrovimab Or Xevudy Market - Company Scoring Matrix
  • Figure 73: GSK plc Financial Performance
  • Figure 74: Vir Biotechnology Inc. Financial Performance
  • Figure 75: Global Sotrovimab Or Xevudy Market, Competitive Benchmarking (In USD Billions)
  • Figure 76: Global Sotrovimab Or Xevudy Market, Competitive Dashboard
  • Figure 77: Global Sotrovimab Or Xevudy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 78: Global, Sotrovimab Or Xevudy Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 79: Global, Sotrovimab Or Xevudy Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030
  • Figure 80: Global, Sotrovimab Or Xevudy Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Antibody Drug Conjugates Market Report 2026 - Global Outlook – By Type (Monoclonal Antibodies, Linker, Drug/Toxin, Other Types ), By Product Brand (Adcertis, Kadcyla, Other Product Brands), By Technology (Immunogen Techn...

Antibody Contract Manufacturing Market Report 2026 - Global Outlook – By Product (Monoclonal Antibodies, Polyclonal Antibodies, Other Products), By Source (Mammalian, Microbial), By Scale Of Operation (Preclinical, Clini...

Next-Generation Antibody Therapeutics Market Report 2026 - Global Outlook – By Types Of Antibodies (Monoclonal Antibodies, Polyclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates, Other Types), By Therapeu...

Antibody Discovery Market Report 2026 - Global Outlook – By Methods (Phage Display, Hybridoma, Other Methods), By Antibody Type (Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody), By End Users (Phar...

Antivirus Software Market Report 2026 - Global Outlook – By Type (Computers, Tablets, Smart Phones, Other Types), By Operating System (Windows, MAC, Android, IOS, Linux), By End User (Corporate, Personal, Government) – M...

Virus Filtration Market Report 2026 - Global Outlook – By Product Type (Virus Filtration Devices, Virus Filtration Consumables, Virus Filtration Systems, Virus Filtration Services), By Filtration Technology (Size-Exclusi...

Herpes Simplex Virus Treatment Market Report 2026 - Global Outlook – By Type (Herpes Simplex Virus-1 Infection, Herpes Simplex Virus-2 Infection), By Drug Type (Acyclovir, Valacyclovir, Famciclovir, Other Drugs), By Rout...

Coronavirus (COVID-19) Current Therapy Market 2025 – By Drug Type (Antivirals, Monoclonal Antibodies (Mabs), Corticosteroid, Supplements, Antimalarial, Interferons And Interleukin Inhibitors, Other Anti Infections, Other...

Frequently Asked Questions

The Sotrovimab Or Xevudy market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

The global Sotrovimab Or Xevudy market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Some Key Players in the Sotrovimab Or Xevudy market Include, GSK plc, Vir Biotechnology Inc. .

Major trend in this market includes: nan. For further insights on this market. request a sample here

North America was the largest region in the sotrovimab or xevudy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sotrovimab or xevudy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us